Miami Herald - February 1, 2008
The kit contains a home collection-test system that requires users to collect a blood specimen and then mail it to a laboratory for professional testing; no test kits allow consumers to interpret the results at home.
Numerous unapproved test systems are currently being marketed, the FDA says. Manufacturers have falsely claimed that their products can detect antibodies to HIV in blood or saliva samples, and that they can provide results in the home in 15 minutes or less. Some have even claimed that their systems have FDA approval or are manufactured in a facility that's FDA-registered. Learn more at www.fda.gov/consumer.
080201
MH080201
Copyright © 2008 - Miami Herald. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Miami Herald, Permissions, One Herald Plaza, Miami, FL 33132-1693 TEL: (305) 376-3719. http://www.herald.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .